Insulin dosing guidance to optimise type 2 diabetes management – Authors' reply

Yet, increased contact with patients without an automated process of glucose pattern analysis, insulin titration, and dose implementation does not lead to substantial alterations in care. The good intentions of providers prescribing insulin around the globe have so far not translated to improved glucose control as documented in the literature.4,5 Clinicians must implement a system ensuring our patients understand that frequent titration of insulin doses (increases and decreases) is essential, and have plans in place to facilitate it. RMB has received research support, consulted, or has been on the scientific advisory board for Abbott Diabetes Care, DexCom, Hygieia, Johnson & Johnson, Lilly, Medtronic, Novo Nordisk, Onduo, Roche, Sanofi, and United Healthcare.